Literature DB >> 3723142

An ultrastructural study of mineralization in craniopharyngiomas.

K Sato, T Kubota, S Yamamoto, A Ishikura.   

Abstract

In eight cases of adamantinomatous craniopharyngioma examined ultrastructurally special attention was paid to the process of mineralization. The tumors were usually composed of neoplastic epithelial cells and fibrous connective tissue stroma. Islands of keratinized cells were frequently observed in the epithelial cell zone. In most of the degenerated keratinized cells cytoplasmic organelles had disappeared except for tonofibrils and membrane-bound round vesicles were seen among the numerous tonofibrils. Needle-shaped crystals were deposited within some vesicles. The accumulation of crystals in the vesicles and the coalescence of calcified vesicles and calcified adjacent tonofibrils resulted in the formation of a large calcified body. Mineralized precipitates were confirmed as calcium and phosphorus by means of an energy dispersive X-ray microanalyzer; the precipitates were composed of hydroxyapatite which was substantiated crystallographically with an X-ray diffractometer. These findings suggest that membrane-bound vesicles derived from degenerated keratinized cells play an important role in the initial process of calcification. The tonofibrils may also serve to orient apatite crystal precipitation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3723142     DOI: 10.1097/00005072-198607000-00007

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  2 in total

1.  Involvement of osteopontin as a core protein in craniopharyngioma calcification formation.

Authors:  SongTao Qi; GuangLong Huang; Jun Pan; Jia Li; Xi'An Zhang; LuXiong Fang; BaoGuo Liu; Wei Meng; YongMing Zhang; XiaoJun Liu
Journal:  J Neurooncol       Date:  2009-11-10       Impact factor: 4.130

2.  Ossified adamantinous type craniopharyngiomas. A series of 13 patients.

Authors:  S Palaoğlu; A Akbay; G Mocan; B Onol; O E Ozcan; T Ozgen; V Bertan
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.